A phase 1 study of the drug ELI-002 reveals promising results, according to researchers from the University of Texas MD Anderson Cancer Center. The vaccine is still in the early stages of development, but so far it has shown results in preventing the recurrence of cancers linked to genetic mutations in the KRAS G12D and […]
Join our Mailing List
Copyright 2024 – NYCTastemakers – All Rights Reserved
Designed by Rivera Marketing & Media Group
